Hemostatic gene polymorphisms and the prevalence of thrombohemorrhagic complications in polycythemia vera and essential thrombocythemia.

被引：0
|
作者：
Afshar-Kharghan, V
Lopez, JA
Gray, LA
Padilla, A
Borthakur, G
Roberts, SC
Pruthi, RK
Tefferi, A
机构：
[1] Baylor Coll Med, Thrombosis Res Sect, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Div Hematol Oncol, Houston, TX USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1967
引用
收藏
页码：471A / 471A
页数：1
相关论文
共 50 条
  • [31] A clinical update in polycythemia vera and essential thrombocythemia
    Tefferi, A
    Solberg, LA
    Silverstein, MN
    AMERICAN JOURNAL OF MEDICINE, 2000, 109 (02): : 141 - 149
  • [32] Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance
    Chiaranairungrot, Kittitat
    Kaewpreechawat, Komkrich
    Sajai, Chanwit
    Pagowong, Narueporn
    Sukarat, Nissa
    Piriyakhuntorn, Pokpong
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Chai-Adisaksopha, Chatree
    Tantiworawit, Adisak
    Norasetthada, Lalita
    Rattarittamrong, Ekarat
    HEMATOLOGY, 2022, 27 (01) : 813 - 819
  • [33] Prevalence and risk factors for aspirin resistance in patients with polycythemia vera and essential thrombocythemia
    Chinthammitr, Y.
    Jianthanakanon, J.
    Nakkinkun, Y.
    Suwanawiboon, B.
    Ruchutrakool, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 337 - 337
  • [34] Thrombotic and hemorrhagic complications after surgery in patients with essential thrombocythemia and polycythemia vera.
    Ruggeri, Marco
    Rodeghiero, Francesco
    Tosetto, Alberto
    Castaman, Giancarlo
    Scognamiglio, Francesca
    Finazzi, Guido
    Delaini, Federica
    Mico, Caterina
    Vannucchi, Alessandro M.
    Antonioli, Elisabetta
    De Stefano, Valerio
    Za, Tommaso
    Gugliotta, Luigi
    Tieghi, Alessia
    Mazzucconi, Maria Gabriella
    Santoro, Cristina
    Barbui, Tiziano
    BLOOD, 2006, 108 (11) : 761A - 761A
  • [35] THROMBOEMBOLISM PREDICTIVE FACTORS IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
    Bellora, A.
    Tamiazzo, S.
    Primon, V.
    Pini, M.
    Corsetti, M. T.
    Cornaglia, E.
    Demichelis, M.
    Santi, R.
    Contino, L.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 410 - 410
  • [36] Interferon-α therapy in polycythemia vera and essential thrombocythemia
    Elliott, MA
    Tefferi, A
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (05): : 463 - 472
  • [37] RESULTS of Allogeneic TRANSPLANTATION for Polycythemia VERA and Essential Thrombocythemia
    Ballen, Karen K.
    Arora, Mukta
    Zhu, Xiaochun
    Agovi, Manza
    Kalaycio, Matt
    Maziarz, Richard T.
    Cortes, Jorge E.
    Woolfrey, Ann
    Horowitz, Mary M.
    Saber, Wael
    BLOOD, 2010, 116 (21) : 1444 - 1445
  • [38] Treatment of polycythemia vera and essential thrombocythemia: The role of Pipobroman
    Passamonti, F
    Lazzarino, M
    LEUKEMIA & LYMPHOMA, 2003, 44 (09) : 1483 - 1488
  • [39] Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
    Reikvam, H.
    Tiu, R. V.
    LEUKEMIA, 2012, 26 (04) : 563 - 571
  • [40] Emerging agents and regimens for polycythemia vera and essential thrombocythemia
    Rory M. Shallis
    Nikolai A. Podoltsev
    Biomarker Research, 9
12345